Article Versions Notes

Załuski M, Karcz T, Drabczyńska A, Vielmuth C, Olejarz-Maciej A, Głuch-Lutwin M, Mordyl B, Siwek A, Satała G, Müller CE, et al. Xanthine–Dopamine Hybrid Molecules as Multitarget Drugs with Potential for the Treatment of Neurodegenerative Diseases. Biomolecules. 2023; 13(7):1079. https://doi.org/10.3390/biom13071079

Załuski, Michał, Tadeusz Karcz, Anna Drabczyńska, Christin Vielmuth, Agnieszka Olejarz-Maciej, Monika Głuch-Lutwin, Barbara Mordyl, Agata Siwek, Grzegorz Satała, Christa E. Müller, and et al. 2023. "Xanthine–Dopamine Hybrid Molecules as Multitarget Drugs with Potential for the Treatment of Neurodegenerative Diseases" Biomolecules 13, no. 7: 1079. https://doi.org/10.3390/biom13071079

Załuski, M., Karcz, T., Drabczyńska, A., Vielmuth, C., Olejarz-Maciej, A., Głuch-Lutwin, M., Mordyl, B., Siwek, A., Satała, G., Müller, C. E., & Kieć-Kononowicz, K. (2023). Xanthine–Dopamine Hybrid Molecules as Multitarget Drugs with Potential for the Treatment of Neurodegenerative Diseases. Biomolecules, 13(7), 1079. https://doi.org/10.3390/biom13071079